Infliximab and Reactivation of Cerebral Toxoplasmosis
NEJM 353:1530-1531, Callegari,P.E., 2005
Use of Complementary and Alternative Therapies in Epilepsy, Cause for Concern
Arch Neurol 62:1472-1475, Pearl,P.L.,et al, 2005
Recent Use of Oral Contraceptives and the Risk of Multiple Sclerosis
Arch Neurol 62:1362-1365, Alonso,A.,et al, 2005
Protein S Deficiency in HIV Associated Ischaemic Stroke:An Epiphenomenon of HIV Infection
JNNP 76:1455-1456,1331, Mochan,A.,et al, 2005
Silent Ischemia in Minor Stroke and TIA Patients Identified on MR Imaging
Neurol 65:513-517, Coutts,S.B.,et al, 2005
MRI Screening Before Standard Tissue Plasminogen Activator Therapy Is Feasible and Safe
Stroke 36:1939-1943, Kang,D.-W.,et al, 2005
Chagas Disease Is an Independent Risk Factor for Stroke
Stroke 36:2015-2017, Oliveira-Filho,J.,et al, 2005
REACH Clinical Feasibility of a Rural Telestroke Network
Stroke 36:2018-2020, Hess,D.C.,et al, 2005
Major Risk Factors for Intracerebral Hemorrhage in the Young Are Modifiable
Stroke 36:1881-1885, Feldmann,E.,et al, 2005
Identification, Prognosis, and Management of Patients with Carotid Artery Near Occlusion
AJNR 26:2086-2094, Fox,A.J.,et al, 2005
Lesion Size Determines Accuracy of Thallium-201 Brain Single-Photon Emission Tomography in Differentiating Between Intracranial Malignancy and Infection in AIDS Patients
AJNR 26:1973-1979, Younhg,R.J.,et al, 2005
Cluster Headache:Pathogenesis,Diagnosis, and Management
Lancet 366:843-855, May,A., 2005
Fatal Brain Necrosis in Primary HIV Infection
Lancet 366:866, Meersseman,W.,et al, 2005
Bilateral Involvement of a Single Cranial Nerve:Analysis of 578 Cases
Neurol 65:950-, Keane,J.R., 2005
Agressive Therapy With Intravenous Abciximab and Intra-Arterial rtPA and Additional PTA/Stenting Improves Clinical Outcome in Acute Vertebrobasilar Occlusion
Stroke 36:1160-1165, Eckert,B.,et al, 2005
Contribution of Atrial Fibrillation to Incidence and Outcome of Ischemic Stroke
Stroke 36:1115-1119, Marini,C.,et al, 2005
Evaluation of C-Reactive Protein Measurement for Assessing the Risk and Prognosis in Ischemic Stroke
Stroke 36:1316-1329, Di Napoli,M.,et al, 2005
Early Carotid Atherosclerosis in Subjects With Periodontal Diseases
Stroke 36:1195-1200, Soder,P-O.,et al, 2005
Perfusion Computed Tomography: Prediction of Final Infarct Extent and Stroke Outcome
Ann Neurol 58:672-679,661, Parsons,M.W.,et al, 2005
Economic Benefit of Increasing Utilization of Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke in the United States
Stroke 36:2500-2503, Demaerschalk,B.M. &Yip,T.R., 2005
Visual Loss Due to a Carious Tooth
Lancet 366:1504-1505, Moschos,M.M.,et al, 2005
Poor Outcomes in Patients Who Do Not Receive Intravenous Tissue Plasminogen Activator Because of Mild or Improving Ischemic Stroke
Stroke 36:2497-2499, Smith,E.E.,et al, 2005
Outcome and Severe Hemorrhagic Complications of Intravenous Thrombolysis With Tissue Plasminogen Activator in Very Old (=80 Years) Stroke Patients
Stroke 36:2421-2425, Berrouschot,J.,et al, 2005
Isolated Monoparesis Following Stroke
JNNP 76:805-807, Paciaroni,M.,et al, 2005
Blinded Pressure and Pain
Lancet 365:2244, Rahim,S.A.,et al, 2005
Bells Palsy
BMJ 330:1374, Piercy, J, 2005
Time to Hospital Arrival, Use of Thrombolytics, and In-Hospital Outcomes in Ischemic Stroke
Neurol 64:2115-2120, Qureshi,A.I.,et al, 2005
Numb Ears in Resurrection:Great Auricular Nerve Injury in Hanging Attempt
Neurol 64:2153-2154, Arias,M.,et al, 2005
A Randomized Controlled Trial of Surgery vs Steroid Injection for Carpal Tunnel Syndrome
Neurol 64:2074-2078,2006, Hui,A.C.F.,et al, 2005
Clinicopath Conf., Pheochromocytoma
NEJM 352:2223-2231, Case 16-2005, 2005
Bells Palsy with Ipsilateral Numbness
JNNP 76:1017-1018, Vanopdenbosch,L.J.,et al, 2005
Utility of an Ultrafast Magnetic Resonance Imaging Protocol in Recent and Semi-Recent Strokes
JNNP 76:1002-1005,905, U-King-Im,J.M.,et al, 2005
Tourettes Syndrome and Deep Brain Stimulation
JNNP 76:992-995, Houeto,J.L.,et al, 2005
Temporal Relationship Between Elevation of Epstein-Barr Virus Antibody Titers and Initial Onset of Neurological Symptoms in Multiple Sclerosis
JAMA 293:2496-2500, Levin,L.I.,et al, 2005
Effect of Stress Related to the 9/11/2001 Terror Attack on Seizures in Patients with Epilepsy
Neurol 64:1815-1816, Klein,P. &van Passel,L., 2005
Sudden Deafness From Stroke
Neurol 64:1817-1818, Leussink,V.,et al, 2005
Menieres Disease or Migraine? The Clinical Significance of Fluctuating Hearing Loss With Vertigo
Arch Otolaryngol Head Neck Surg 131:457-460, Boyev,K.P., 2005
Is This Patient Having a Stroke?
JAMA 293:2391-2402, Goldstein,L.B. &Simel,D.L., 2005
Triaging Transient Ischemic Attack and Minor Stroke Patients Using Acute Magnetic Resonance Imaging
Ann Neurol 57:848-854, Coutts,S.B.,et al, 2005
High Titers of CA-125 May Be Associated weith Recurrent Ischemic Strokes in Patients with Cancer
Neurol 64:1944-1945, Jovin,T.G.,et al, 2005
TENS for the Treatment of Writers Cramp Dystonia:A Randomized, Placebo-Controlled Study
Neurol 64:1946-1948, Tinazzi,M.,et al, 2005
Sezirues and Cerebral Schistosomiasis
Arch Neurol 62:1008-1010, Betting,L. E.,et al, 2005
Thrombolytic Therapy of Acute Ischemic Stroke: Correlation of Angiographic Recanalization with Clinical Outcome
AJNR 26:880-884, Zaidat,O.O.,et al, 2005
Cerebral MR Imaging in Uninfected Children Born to HIV-Seropositive Mothers and Perinatally Exposed to Zidovudine
AJNR 26:695-701,687, Tardieu,M.,et al, 2005
Clinicopath Conf, Neurofibromatosis Type 1, with Multiple Spinal Neurofibromas
NEJM 352:1800-1808, Case 13-2005, 2005
Body Fat Distribution and Long-Term Risk of Stroke Mortality
Stroke 36:1021-1025, Tanne,D.,et al, 2005
Perfusion-Weighted Imaging/Diffusion-Weighted Imaging Mismatch on MRI Can Now be Used to Select Patients for Recombinant Tissue Plasminogen Activator Beyond 3 Hours
Stroke 36:1099-1100, 1100, Zivin,J.A., 2005
Physical Methods for Preventing Deep Vein Thrombosis in Stroke
Stroke 36:1102-1103, Grandi,F.C.,et al, 2005
Does This Patient Have Myasthenia Gravis?
JAMA 293:1906-1914, Scherer,K.,et al, 2005
Perfusion-Weighted Imaging/Diffusion-Weighted Imaging Mismatch on MRI Can Now Be Used to Select Patients for Recombinant Tissue Plasminogen Activator Beyond 3 Hours
Stroke 36:1098-1099,1100, Schellinger,P.D. &Fiebach,J.B., 2005